184
Participants
Start Date
April 2, 2012
Primary Completion Date
May 31, 2013
Study Completion Date
June 10, 2013
ARRY-502, CRTh2 antagonist; oral
multiple dose, single schedule
Placebo; oral
matching placebo
University of Pittsburgh Asthma Institute, Pittsburgh
Chesapeake Clinical Research Inc, Baltimore
North Carolina Clinical Research, Raleigh
Clinical Neuroscience Solutions, Jacksonville
Allergy & Asthma Diagnostic Treatment Center, Tallahassee
Florida Pulmonary Research Institute, Winter Park
South Florida Research Trials, Miami
Pulmonary Disease Specialists, Kissimmee
Toledo Center for Clinical Research, Sylvania
Allergy, Respiratory & Sleep Center, Canton
Bernstein Clinical Research, Cincinnati
Allergy Asthma & Sinus Center, S.C., Greenfield
Asthma Allergy & Pulmonary Research, Madison
Clinical Research Institute, Minneapolis
Clinical Research Institute, Plymouth
Clinical Research Group of Montana, Bozeman
Sneeze, Wheeze & Itch, Normal
The Asthma & Allergy Center, Bellevue
IPS Research Company, Oklahoma City
Allergy Asthma & Clinical Research Center, Oklahoma City
Vital Prospects Clinical Research Institute, PC, Tulsa
Pharmaceutical Research & Consulting Inc., Dallas
Central Texas Health Research, New Braunfels
Sylvana Research Associates, San Antonio
Tekton Research, Austin
Western Sky Medical Research Inc, El Paso
Rocky Mountain Center for Clinical Research, Wheat Ridge
Colorado Allergy and Asthma Center, Centennial
IMMUNOe International Research Centers, Centennial
Asthma & Allergy Associates PC, Colorado Springs
Idaho Research, Eagle
Allergy Medical Clinic - Research Division, Los Angeles
California Allergy & Asthma Med. Group, Los Angeles
Southern California Institute for Respiratory Diseases Inc, Los Angeles
Peninsula Research Associates, Rolling Hills Estates
Allergy Associates Medical Group, San Diego
Allergy & Asthma Specialists Medical Group, Huntington Beach
Southern California Research, Mission Viejo
Baker Allergy, Asthma & Dermatology Research Center, Lake Oswego
Clinical Research Institute of Southern Oregon, Medford
Asthma Inc., Seattle
Northeast Medical Research Associates, North Dartmouth
Princeton Center for Clinical Research, Skillman
Lead Sponsor
Pfizer
INDUSTRY